Monday, 26 January 2015   
New 'systems genetics' study identifies possible target for epilepsy treatment
A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new treatments, according to research. Epilepsy is a common and serious disease that affects around 50 million people worldwide. The mortality rate among people with epilepsy is two to three times higher than the general population.It is known that epilepsy has a strong genetic component, but the risk is related to multiple factors that are 'spread' over hundreds of genes. Identifying how these genes are co-ordinated in the brain is important in the search for new anti-epilepsy medications. This requires approaches that can analyse how multiple genes work in concert to cause disease.
 
Wednesday, 14 January 2015   
World leaders gathering at Davos face calls for bold action to turn the tide on cancer
World leaders will face calls for bold action to respond to the rising human and economic toll of cancer when they meet in Davos at this year's World Economic Forum (WEF). Two sessions have been scheduled where international political, civic and business leaders have the chance to discuss how they can work with the cancer community to turn the tide on cancer: Cancer Pathway to a Cure - What are the breakthroughs in cancer prevention and therapy? - an interactive dinner session on Friday January 23rd; Globalization of Non-Communicable Diseases, a working session on the morning of Saturday January 24th.
 
Thursday, 08 January 2015   
Newly discovered antibiotic kills pathogens without resistance
For years, pathogens' resistance to antibiotics has put them one step ahead of researchers, which is causing a public health crisis, according to University Distinguished Professor Kim Lewis. But in new research, Lewis and his colleagues present a newly discovered antibiotic that eliminates pathogens without encountering any detectable resistance - a finding that challenges long-held scientific beliefs and holds great promise for treating chronic infections like tuberculosis and those caused by MRSA. The research was published Wednesday in the journal Nature.
 

Research & Development

New 'systems genetics' study identifies possible target for epilepsy treatment

A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new...

World leaders gathering at Davos face calls for bold action to turn the tide on cancer

World leaders will face calls for bold action to respond to the rising human and economic toll of cancer when...

Newly discovered antibiotic kills pathogens without resistance

For years, pathogens' resistance to antibiotics has put them one step ahead of researchers, which is causing a public health...

IMI launches €115 million Calls for proposals to develop vaccines & medicines of the future

The Innovative Medicines Initiative (IMI) and the Bill and Melinda Gates Foundation are to collaborate on a project to improve...

More in: Research & Development

Conferences & Events

mHealth Summit Europe 2015 and eHealth Week join forces

11 - 12 May 2015, Riga, Latvia. The mHealth Summit Europe will be back in 2015 as a part of eHealth Week in Riga, Latvia. The Summit will be opening...

European Telemedicine Conference 2014

7 - 8 October 2014, Rome, Italy. The European Telemedicine Conference (ETC) 2014 will combine the efforts of several leading European Healthcare Organisations into one powerful event. The conference will...

Medical Entrepreneur Start-up Hospital - M.E.S.H Camp 2014

17 - 18 September 2014, Berlin, Germany. Anyone who's ever tried to launch a start-up knows how hard it is. It takes all you've got to succeed. DocCheck Guano organises...

Biovision presents its selection of 44 promising life sciences businesses and projects

5 - 6 June 2014, Lyon, France. Biovision, the annual forum on future-oriented research in life sciences, today announces the list of biotech and medtech companies and projects selected for...

Delegates from more than 30 countries to share the benefits of eHealth at WoHIT 2014

2 - 4 April 2014, Nice, France. The World of Health IT Conference and Exhibition 2014 (WoHIT 2014), taking place in Nice, France, presents a comprehensive international programme with 18...

More in: Conferences & Events

EC Pharmaceuticals

Medicines for children: more research, more availability and more information compared with 5 years ago

News image

Recently, the Commission has publisheed a progress report on medicines for children covering the five years since the Paediatric Regulation came into force. This preliminary snapshot points to improvements in...

New symbol to identify medicines undergoing additional monitoring

News image

An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a legal act adopted by the European Commission today. The symbol...

Launch of EU Rapid Alert platform for human Tissues and Cells

News image

A secure alert platform launched by the European Commission will improve the safety of patients undergoing transplantation and medical procedures involving human tissues and cells, e.g. bone marrow, cornea, skin,...

Commission proposes faster access to medicines for patients

News image

Medicines should enter the market faster. With this intention the European Commission has proposed today to streamline and reduce the duration of national decisions on pricing and reimbursement of medicines....

Pricing and reimbursement of medicines: Commission consults on EU transparency rules

News image

The European Commission has launched a public consultation in view of modernising rules on the transparency of Member States’ decisions regarding the pricing and reimbursement of medicines. The consultation invites...

More in: European Commission

EMA News

Europe to boost cooperation with international partners on generics

News image

The European Union's decentralised procedure is being used as a model to accelerate the assessment of applications for generic medicines as part of the International Generic Drug Regulators Pilot(IGDRP). The...

European Medicines Agency recommends 39 medicines for human use for marketing authorisation in first half of 2014

News image

Thirty-nine medicines for human use were recommended for marketing authorisation by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared...

EMA publishes 2013 annual report

News image

The European Medicines Agency (EMA) has published today its 2013 annual report. In 2013, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended 81 medicines for human use...

Committee for orphan medicines - overview of 2013 and looking ahead

News image

A total of 11 out of 81 medicines recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2013 were intended...

More in: EMA